Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.60    -0.60 (-0.58%)
Bid:
102.00
Ask:
102.80
Spread: 0.80 (0.784%)
Market Cap: £168.21m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Directorate Change

25 Nov 2011 07:00

RNS Number : 7382S
Yule Catto & Co PLC
25 November 2011
 



 

25 November 2011

 

 

 

 

Yule Catto & Co plc

 

Appointment of Dominique Fournier as an Independent Non-executive Director

 

 

Yule Catto & Co plc ("Yule Catto" or the "Company") is pleased to announce that Dominique Fournier will join the Board as an Independent Non-executive Director with effect from 1 January 2012.

 

M. Fournier, 61, is currently Chief Executive of Infineum International Limited, a global specialty chemicals joint venture between Shell and ExxonMobil. He is due to retire from Infineum at the end of this year, after seven years in the role.

 

He has over 35 years of European and US experience in the chemical industry having held a wide variety of roles during that period at Exxon Mobil Chemical and Infineum.

 

Commenting on the appointment Peter Wood, Chairman, said:

 

"Dominique brings a wealth of international chemical industry experience which complements the Board's existing expertise and we look forward to working with him."

 

On his appointment to Yule Catto's Board, M. Fournier will join its Audit and Remuneration Committees.

 

There are no further details to be notified under listing rule 9.6.13 in relation to M. Fournier's appointment.

 

 

Enquiries:

 

Yule Catto

Adrian Whitfield, Chief Executive Tel: 01279 442791

 

MHP Communications

Andrew Jaques / John Olsen / Ian Payne Tel: 020 3128 8100

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFIELELSFIL
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.